DIAPRIDE M 0.5 (Glimepiride (0.5mg) + Metformin (500mg))

Diapride M 0.5mg/500mg Tablet is classified within a group of medications referred to as anti-diabetic agents. This formulation combines two active ingredients aimed at managing type 2 diabetes mellitus in adults. Its primary function is to assist in regulating blood sugar levels for individuals diagnosed with diabetes. Administration of Diapride M is recommended to occur alongside food, and it should be taken consistently at the same time each day to optimize its effectiveness. The prescribing physician will determine the appropriate dosage for each patient, which may be adjusted periodically based on blood sugar monitoring results. It is crucial to continue using this medication even if symptoms improve or blood sugar appears stable. Abruptly discontinuing the tablet without medical guidance could lead to increased blood sugar levels, raising the risk of severe complications such as kidney impairment, vision loss, neuropathy, and potential amputation. It is vital to understand that this medication is only a portion of a comprehensive treatment plan that includes a balanced diet, consistent physical activity, and weight management as recommended by a healthcare provider. Lifestyle modifications significantly contribute to effective diabetes management. The predominant adverse reaction observed with Diapride M is hypoglycemia, a state of low blood sugar. It is essential to be aware of the signs and symptoms of this condition, including sweating, dizziness, headaches, and tremors, and to know how to address them. To mitigate the risk of hypoglycemia, regular meal intake is advisable, and carrying a source of rapid glucose, like candy or fruit juice, is recommended. Alcohol consumption should be avoided as it may heighten the likelihood of low blood sugar episodes. Other potential side effects linked to this medication include altered taste sensations, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections. Additionally, some individuals may experience weight gain while on this treatment. Diapride M is contraindicated for individuals with type 1 diabetes mellitus, diabetic ketoacidosis, or significant renal or hepatic impairment. Patients with a history of cardiac issues should inform their healthcare provider prior to use. Pregnant and breastfeeding individuals are advised to consult their physician prior to starting this medication. Regular blood sugar checks are necessary, and healthcare practitioners may recommend laboratory tests to monitor blood cell counts and liver health during treatment.